Market Tracker

11/21 6:05pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

35.33
Data as of Nov 21
 +1.81 / +5.40%
Today’s Change
17.32
Today|||52-Week Range
53.48
+60.52%
Year-to-Date
50/50 Basket Update
Nov 08 / StockTwits
Ebola: The making of a $1 billion drug
Oct 28 / CNNMoney.com
Position Updates
Nov 01 / StockTwits
The Ebola stocks: Effect of an outbreak
Oct 24 / CNNMoney.com
50/50 Basket Update
Oct 29 / StockTwits
 

Today’s Trading

Previous close33.52
Today’s open33.70
Day’s range33.01 - 35.83
Volume1,300,023
Average volume (3 months)1,080,992
Market cap$987.8M
Dividend yield--
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)-9.82%
Earnings growth (this year)-33.74%
Earnings growth (next 5 years)--
Revenue growth (last year)-35.21%
P/E ratioNM
Price/Sales508.97
Price/Book16.10

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...+0.19+0.51%
MACKMerrimack Pharmaceut...-0.07-0.77%
FWPForward Pharma A/S-0.18-0.88%
EBSEmergent BioSolution...+0.30+1.24%
Data as of 4:02pm ET, 11/21/2014

Financials

Next reporting dateFebruary 26, 2015
EPS forecast (this quarter)-$0.71
Annual revenue (last year)$1.1M
Annual profit (last year)-$31.2M
Net profit margin-2,852.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts